NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients

Clinical Significance of NPM1 A and Non A Mutations and Its Relation to The ARF/P53 Pathway in Egyptian Acute Myeloid Leukemia Patients

CD47 Expression in Egyptian Patients with Acute Myeloid Leukemia

Evaluation of ADAM28 expression in adult Egyptian Acute Myeloid Leukemia patients and its impact on outcome

Expression of Heparanase Gene in Egyptian Acute Leukemia Patients

Outcome of acute myeloid leukemia with recurrent cytogenetic abnormalities; A retrospective study in South Egypt Cancer Institute Rania Bakry;1AsmaaOmar,2Abeer M. Darwish,3Rania H

Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt

IL‑17F and IL- 23 gene polymorphism in patients with acute myeloid leukemia, an Egyptian study

Fms-Like Tyrosine Kinase 3 expression in Childhood Acute lymphoblastic Leukemia at South Egypt Cancer Institute, Assiut University, Egypt

Prom-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome